SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Harold Engstrom who wrote (643)2/17/2000 2:29:00 PM
From: Jim Oravetz  Respond to of 52153
 
2/17 13:04 ET Leading Tech Gainers : HGSI +36 3/4... INCY +34 1/2... AFFX +30... MLNM +34 1/2... WEBM +29 13/16... MYGN +29... DVSA +27... ALKS +23... CRGN +22... HYSQ +19 1/2... GLGC +17... MAXY +16 1/4... Of these stocks, all but two are biotech related. Even biotech doyen Biogen (BGEN 122 7/16 +14 7/8) has been picked up in the rally

10:33 ET Small-Cap Biotech Movers : Repligen (RGEN 10 1/2 +2 )... Interneuron Pharmaceutical (IPIC 5 5/8 +3 5/32)... Magainin Pharmaceuticals (MAGN 5 1/16 +11/16)... Senetek PLC (SNTKY 2 19/32 +15/32)... CytRx (CYTR 3 1/8 +9/16).

Source: Briefing.com
Jim



To: Harold Engstrom who wrote (643)2/17/2000 2:56:00 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Harold,

I own ELN. Check out the biased and negative (and partly flat wrong) Eisinger (ex-thestreet.com) article about it in the WSJ recently for an idea of why it's still cheap.

Agree that GLIA is still cheap. Also IGEN and AZA look cheap to me, and FRX is also fairly attractive.

That's of course assuming you want to be buying "cheap" stocks in the first place in this environment <g>

Peter